The launch of our book, Private M&A in Canada: Transactions & Litigation, further exemplifies our team's nation-wide M&A strength.

Toronto (Canada) – Fasken continued its remarkable performance in the first quarter of 2024 with No. 1 rankings as legal advisor for M&A transactions in league tables released by LSEG Data & Analytics (formerly Refinitiv) and Mergermarket.

Detailed Q1 2024 M&A league table rankings include:

  • #1 for completed deals with any Canadian involvement by deal count (LSEG Data & Analytics)
  • #1 for announced deals with any Canadian involvement by deal count (LSEG Data & Analytics)
  • #1 for Canadian M&A deals by deal count (Mergermarket)

These results, coupled with the launch of Private M&A in Canada: Transactions & Litigation, Canada's first comprehensive book on private M&A, reflect our team's nation-wide M&A strength and commitment to outstanding client service, as well as our forward-thinking, multi-disciplinary approach.

Additional resources, including the latest market-leading thought leadership, can be found in our Capital Markets and Mergers & Acquisitions Knowledge Centre.

Fasken's Mergers & Acquisitions practice group is a clear leader in Canada and among Canada's largest, advising our clients on the most complex and noteworthy transactions and cross-border deals. The group also calls upon the Firm's deep bench for industry specific expertise and advice on regulatory matters including tax strategy, anti-trust and foreign investment, labour and employment, intellectual property, sanctions and corrupt practices and government relations.

Fasken's Capital Markets practice group is a recognized leader in Canada with over 175 lawyers on our team, regularly acting for issuers and underwriters on Canada's most complex corporate finance transactions. A key to our success is our proven ability to maintain longstanding relationships with our publicly traded clients (many of which we have been advising since their IPO) that extend beyond capital markets transactions and throughout their lifecycle as publicly-traded issuers.